Optipharm.CO.,LTD (153710.KQ)
- Previous Close
5,210.00 - Open
5,140.00 - Bid 5,100.00 x --
- Ask 5,110.00 x --
- Day's Range
5,030.00 - 5,210.00 - 52 Week Range
4,400.00 - 7,640.00 - Volume
18,491 - Avg. Volume
8,244 - Market Cap (intraday)
75.844B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea.
www.optipharm.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 153710.KQ
View MorePerformance Overview: 153710.KQ
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 153710.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 153710.KQ
View MoreValuation Measures
Market Cap
75.84B
Enterprise Value
72.62B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.85
Price/Book (mrq)
2.77
Enterprise Value/Revenue
3.70
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.00%
Return on Assets (ttm)
-3.71%
Return on Equity (ttm)
-8.98%
Revenue (ttm)
19.64B
Net Income Avi to Common (ttm)
-2.36B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
14.23B
Total Debt/Equity (mrq)
40.27%
Levered Free Cash Flow (ttm)
-1.01B